|
Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) |
|
Zentalis Pharmaceuticals Inc
ZNTL's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Zentalis Pharmaceuticals Inc 's sales fell
in III. Quarter 2024 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
growth of revenues by 9.75 %
Zentalis Pharmaceuticals Inc net loss decreased from $-56 millions, to $-40 millions in III. Quarter 2024,
• More on ZNTL's Growth
|
|
Zentalis Pharmaceuticals Inc realized a net loss in trailing twelve months.
Zentalis Pharmaceuticals Inc realized cash reduction of $ -0.98 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 4.26.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.4.
• More on ZNTL's Valuation
|
|
|
|
|
Zentalis Pharmaceuticals Inc realized net loss in trailing twelve months.
Zentalis Pharmaceuticals Inc realized cash outflow of $ -0.98per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 4.26.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.4.
Zentalis Pharmaceuticals Inc Price to Book Ratio is at 0.49 lower than Industry Avg. of 87.76. and higher than S&P 500 Avg. of 0.02
• More on ZNTL's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com